COPLX
Price
$200.00
Change
-$0.82 (-0.41%)
Updated
Aug 19 closing price
Net Assets
107.75M
VIVIX
Price
$70.65
Change
+$0.33 (+0.47%)
Updated
Aug 19 closing price
Net Assets
195.81B
Interact to see
Advertisement

COPLX vs VIVIX

Header iconCOPLX vs VIVIX Comparison
Open Charts COPLX vs VIVIXBanner chart's image
Copley Fund
Price$200.00
Change-$0.82 (-0.41%)
VolumeN/A
Net Assets107.75M
Vanguard Value Index I
Price$70.65
Change+$0.33 (+0.47%)
VolumeN/A
Net Assets195.81B
COPLX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
COPLX vs. VIVIX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COPLX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 196B vs. COPLX (108M). VIVIX pays higher dividends than COPLX: VIVIX (2.19) vs COPLX (0.00). COPLX was incepted earlier than VIVIX: COPLX (47 years) vs VIVIX (27 years). COPLX (1.11) is less costly to investors than VIVIX (0.04). VIVIX is a more actively managed with annual turnover of: 9.00 vs. COPLX (5.54). COPLX has a lower initial minimum investment than VIVIX: COPLX (1000) vs VIVIX (5000000). COPLX annual gain was more profitable for investors over the last year : 19.34 vs. VIVIX (7.59). VIVIX return over 5 years is better than : 70.23 vs. COPLX (65.27).
COPLXVIVIXCOPLX / VIVIX
Total Expense Ratio1.110.042,775%
Annual Report Gross Expense Ratio1.110.042,775%
Fund Existence47 years27 years-
Gain YTD11.1416.548170%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets108M196B0%
Annual Yield % from dividends0.002.19-
Returns for 1 year19.347.59255%
Returns for 3 years44.5427.04165%
Returns for 5 years65.2770.2393%
Returns for 10 years195.06127.45153%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDSB1.240.05
+4.20%
PDS Biotechnology Corp
MASI153.930.06
+0.04%
Masimo Corp
TAVIU10.54N/A
N/A
Tavia Acquisition Corp
IMCR32.31-0.57
-1.73%
Immunocore Holdings plc
TNXP40.07-11.28
-21.97%
Tonix Pharmaceuticals Holding Corp